Kedrion-Pharmacosmos partnership for the treatment of Anemia in Italy
Exclusive agreement signed for the distribution of a novel iron-based therapy
Results of the “Words in Hemophilia: Towards Patient Engagement” study have been published
The project supported by Kedrion defines some of the key principles intended to improve patient envolvement
Kedrion and LFB sign industrial cooperation agreement
Scope is supplying Immunoglobulins to meet patient demand in France
Kedrion was one of the main supporters of the ASNP Annual Meeting
A multidisciplinary reflection at the center of the Scientific symposium supported by the company
Kedrion supports young scientists: awarding the Guelfo Marucci prize
Two scholarships awarded to research projects in the field of non-oncological hematology
“Fabrizio Fabbrizzi” research prizes awarded in Lucca
The initiative was promoted by Kedrion with a contribution by the PPTA
Kedrion grows in North America as it completes acquisition of Prometic
Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficiency
Kedrion was one of the main supporters of the 2021 AICE Annual Convention
The company supported a scientific reading on prophylaxis in patients with von Willebrand disease
Kedrion supports Italian liver transplantology
The company supported the Italian National Continuing Medical Education Program (ECM) event organized by Epateam aimed at specialists in the field
